Reading room

Investment Strategies in Tech Start-up

Posted by:
Posted in: Corporate solutions
Date published: 19/08/2024

Get in touch with our corporate lawyers in the UK and call us on 0330 107 0106 to arrange a free no no-obligation call or request a free quote.

One of the core concerns of any start-up is the initial raising of capital which, in particular with outside investment, requires a careful and considered structuring of equity financing to protect the interests of the founders and the business whilst balancing the interests of the investors.

This case study examines a challenging investment scenario involving a breakthrough AI business in the healthcare market. The company, which is presently valued at around £10 million, recently closed an early funding round open to outside investors. This examination falls into the legal complexities encountered by existing shareholders, including the founders, as they navigated the investment, the issuance of equity shares, and the structural changes that were necessary to protect their interests and the company’s future.

Background

The company at the centre of this case is an emerging AI healthcare enterprise, valued at £10 million. During an early investment round, an individual investor committed a substantial investment sum in exchange for equity shares which nonetheless entitle the investor to a share in future profits. This investment was formalised through a subscription agreement together with a number of commercial documents, with provisions for the issuance of shares and subsequent payment to the investor on fulfilment of a number of conditions.

Key Legal Issues

1. Subscription Agreement

The subscription agreement was an important document that specified the circumstances under which the investor would obtain equity shares. It was essential to ensure that the agreement:

  • Clearly stated conditions for equity share allotment.
  • Established timing and nature of investment payments to protect the company’s interests.
  • Included provisions for clawback rights in case of breaches of the subscription agreement together with a dispute resolution mechanism to minimise the legal costs of either party in the unlikely event of a disagreement arising.

2. Investor Involvement and Commission

Beyond financial investment, the investor was to play an active role in introducing the company to new commercial opportunities globally. In order to accommodate these obligations on the investor and to ensure that the relevant profit split could be catered for in the contracting documents, separate commercial agreements, working in unison with the subscription agreement were entered into by the company and the investor.

This arrangement required careful legal structuring to:

  • Define the scope and nature of the investor’s involvement.
  • Establish clear terms for the profit share to be paid for successful business introductions.
  • Ensure compliance with international regulations given the cross-jurisdictional nature of the investor’s activities.
  • Ensure that the commercial arrangement supplemental and complimentary to the subscription agreement.

3. Share and Capital Structure Adjustments

To accommodate the new investment, the company had to undergo significant changes in its share and capital structure. Key considerations included:

  • The buyback of certain shares from current shareholders under previously reserved provisions.
  • Protecting the interests of existing shareholders while integrating the new investor’s contributions.
  • Ensuring that the revised structure did not dilute the control or value of existing shares unduly.

Legal Strategy and Execution

Protecting Shareholder Interests

The legal team prioritised safeguarding the interests of the current shareholders by:

  • Negotiating clawback measures to protect the company in case the investor fails to meet payment obligations. 
  • Structuring share purchase agreements and reinstatement to protect current shareholders’ control and value.

Structuring the Investor’s Role

To clearly delineate the investor’s operational role, the legal team:

  • Drafted a detailed agreement outlining the investor’s responsibilities and the conditions under which commissions would be paid.
  • Ensured compliance with international laws, particularly those governing business operations and commission payments in different jurisdictions.

Conclusion and Key Takeaways

This case study highlights several critical takeaways for corporate law practitioners involved in similar investment scenarios:

  • Clear and Comprehensive Agreements: Detailed subscription agreements with clear conditions and clawback provisions are vital in protecting a company’s interests.
  • Structuring Investor Roles: When investors are involved beyond financial contributions, their roles must be meticulously defined to avoid potential conflicts and ensure legal compliance.
  • Share and Capital Structure Management: Adjusting a company’s share and capital structure to accommodate new investments requires careful planning to protect existing shareholders and maintain company stability.
  • Cross-Jurisdictional Compliance: Involving international elements necessitates a thorough understanding of the regulatory environments across different jurisdictions to avoid legal pitfalls.

By focusing on these elements, IMD Corporate team effectively navigated the complicated nature of this investment scenario, ensuring the company’s interests were protected while facilitating growth and new opportunities. This case serves as a valuable guide for handling similar investment rounds in the dynamic and highly regulated healthcare industry.

This case study demonstrates the demanding approach required in corporation law to manage complicated investment circumstances, resulting in strong legal frameworks that enable business growth while protecting stakeholder interests.

Keywords

  • Investment in AI Healthcare
  • Subscription Agreement
  • Non-voting Shares
  • Share and Capital Structure
  • Cross-Jurisdictional Compliance
  • Investor Role Definition
  • Clawback Provisions
  • Protecting Shareholder Interests

This article is for general information only and does not constitute legal or professional advice. Please note that the law may have changed since this article was published.

To find out more about our services, visit Corporate Solutions section of our website.

Call us now to discuss your case 0330 107 0106 or email us at business@imd.co.uk.

Published by:

Olexandr KyrychenkoPartner

Business Services – IMD Corporate

Awards and Accreditations